Preclinical results show a new neuroprotective medicine which 'switches on' cell defenses, could significantly slow disease progressionResearchers at ...

A research team from the School of Engineering at The Hong Kong University of Science and Technology (HKUST) has achieved a ...

Adolescence, the life stage that marks the transition between childhood and adulthood, is known to be a vital period for the brain's development. During this critical phase, people's mental abilities, ...

The anguish isn't over lost memories, but losing the people we love while still alive. The cruelest Alzheimer's symptom is ...

Scholar Rock Holding Company ( SRRK) is a Boston-based, clinical-stage biotech that was founded in 2012, focusing on ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Aligned with U.S Food and Drug Administration (FDA) on design of planned Phase 3 clinical trial of neflamapimod in patients with dementia with ...

DWTX READ THE FULL DWTX RESEARCH REPORT Business Update 100 Patients Enrolled in Phase 2b Trial of Halneuron®; Interim ...

A new medicine, discovered by scientists, protects nerve cells damaged by motor neurone disease (MND), offering hope of substantially slowing the progression of "one of the cruellest diseases".

A strong relationship exists between sleep and brain health. Long-term sleep disruptions can increase the risk of neurodegenerative disorders.